Lattanzi, Michael
Balar, Arjun V.
Article History
First Online: 26 February 2019
Compliance with Ethical Standards
:
: Michael Lattanzi has no conflicts of interest.Arjun V. Balar has received research funding from AstraZeneca/MedImmune, Genentech/Roche, Merck, and Seattle Genetics/Astellas and has received compensation from AstraZeneca/MedImmune, Genentech/Roche, Merck, Incyte, Seattle Genetics/Astellas, Cerulean Pharma, Pfizer/EMD Serono, and Eli Lilly for service as a consultant/advisor.
: This review article does not report any primary data derived from human or animal subjects.